Value-based health care: issues for pharmaceutical companies
Michael Lampert, Ropes & Gray health care partner, discusses issues facing pharmaceutical companies with the move towards value-based health care models.
Trending Similar Videos
Value-based health care: compliance infrastructure
Brett Friedman, Ropes & Gray health care partner, discusses the impact to compliance organizations as payment models transition from traditional fee-for-service to value-based.
Pending Supreme Court PTAB cases
Scott McKeown, Ropes & Gray IP litigation partner and chair of the firm’s Patent Trial and Appeal Board (PTAB) group, discusses potential impacts of pending Supreme Court PTAB cases, Oil States and SAS Institute.
Donations to patient assistance charities
Laura Hoey, Ropes & Gray litigation & enforcement partner, examines the increased enforcement of donations from drug manufacturers to patient assistance charities.
Anti-corruption & international risk developments
Alex Rene, co-chair of Ropes & Gray’s anti-corruption / international risk practice and managing partner of the firm’s Washington, D.C. office, discusses recent FCPA enforcement activity as well as international risks facing companies.
Private equity investments
Neill Jakobe, Ropes & Gray private equity partner and managing partner of the firm’s Chicago office, discusses some of the key trends impacting private equity investments.
False Claims Act: Implied Certification Theory
Kirsten Mayer, Ropes & Gray litigation & enforcement partner, examines the implied certification theory of liability under the False Claims Act.